Press Releases

NEW YORK, March 12, 2020 /PRNewswire/ -- In response to rising concerns of COVID-19, EmblemHealth, one of the nation's largest non-profit health insurers, announced they are partnering with Medly Pharmacy to provide direct, at-home delivery of prescriptions to their members.Medly Pharmacy is a full-service digital pharmacy that delivers prescription medication ri

NEW YORK, March 12, 2020 /PRNewswire/ -- WebMD Health Corp., an Internet Brands company and the leader in health information services for consumers, physicians, and other healthcare professionals, today announced that it has acquired The StayWell Company, a subsidiary of Merck, known as MSD outside the United States and Canada. &nbs

John Hopkins professor and psychedelics expert Matthew Johnson to act as senior advisor to committee NEW YORK, March 12, 2020 /PRNewswire/ -- 

ALHAMBRA, Calif., March 12, 2020 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, announced today its consolidated financial results for the fourth quarter and year ended December 31, 2019."We closed out 2019 on a high note and are very pl

TOLEDO, Ohio, March 12, 2020 /PRNewswire/ -- Hylant, one of the largest privately held insurance brokers in the U.S., has partnered with Regenexx, a network of leading interventional orthopedics clinics. The partnership allows Hylant to offer its clients Regenexx procedures, giving employees access to non-surgical treatments that replace 70% of what was previously

SHANGHAI, March 12, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2019. Fourth Quarter 2019 Highlights

SEATTLE and VANCOUVER, British Columbia, March 12, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced that additional analyses from the ORCA-1 Phase 2b

STOCKHOLM, March 12, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, introduces Coronary Intermediate as the latest software addition to the Coronary Product Portfolio. Coronary Intermediate follows the introduction of Coronary Essentials three months earlier at the 20th International Meeting on Simulation

CAMBRIDGE, Mass., March 12, 2020 /PRNewswire/ -- Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to invent breakthrough protein degrader medicines for patients, today announced the closing of a $102 million Series C financing. The round was led by Biotechnology Value Fund (BVF) and Redmile Grou

LOS ANGELES, March 12, 2020 /PRNewswire/ -- Pulling no punches, the UCLA Anderson Forecasts for the national, state and global economies take a hard look at the potential impacts of COVID-19.